Literature DB >> 2081843

[HLA antigenicity of normal and pathological corneas].

B Delbosc1, D Fellmann, X Piquot, M Montard, J Royer.   

Abstract

Fresh human corneas and corneal buttons were studied for expression of HLA antigens. Using monoclonal antibodies in an indirect immunofluorescence assay, corneal layers were examined for class I (HLA-A, B, C) and class II (HLA-DR) histocompatibility antigens. Twenty-one human corneas were studied, 6 normal and 15 pathological: 4 buttons of allograft rejection, 9 buttons of pseudophakic bullous keratopathy. In fresh control corneas, HLA-A, B, C antigens were localized on corneal epithelium and on stromal keratocytes but were never found on endothelial cells. HLA-DR antigens were not detected on corneal epithelium, stroma or endothelium but were detected on Langerhans cells within epithelium and anterior stroma. At the corneal limbus, HLA class I-II antigens were expressed on vascular endothelium. HLA antigen distribution was modified in pathological corneas. Antigens HLA-A, B, C were induced on endothelial cells of rejected corneal allografts. Antigens HLA-DR were detected on epithelial cells, cells in the stroma of pseudophakic bullous keratopathy and also on endothelial cells of rejected corneal allografts. These results suggest that induction of class I and II antigen expression by inflammatory factors may occur in vivo. In rejected corneal allografts induction of HLA-DR antigen on corneal layers would intensify the process of rejection. This study and others have demonstrated the ability of modulation of HLA antigen expression on human corneal cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2081843

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

1.  Cell subpopulations in failed human corneal grafts.

Authors:  L Kuffová; V Holán; L Lumsden; J V Forrester; M Filipec
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

Review 2.  Immunology and Donor-Specific Antibodies in Corneal Transplantation.

Authors:  Joanna Major; Bartosz Foroncewicz; Jacek Paweł Szaflik; Krzysztof Mucha
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-11-06       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.